Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
The UK starts a 24-week bird flu vaccine trial in turkeys to combat deadly HPAI, which costs up to £174 million yearly.
The UK has begun a 24-week trial of a bird flu vaccine in turkeys to assess its efficacy against highly pathogenic avian influenza (HPAI), which has caused severe losses in poultry and costs up to £174 million per year.
The DEFRA-led trial, which has been approved by the Veterinary Medicines Directorate, focuses on turkeys due to their high vulnerability.
While routine poultry vaccination is still restricted in the UK due to trade and detection concerns, the study aims to assess real-world protection, surveillance integration, and potential impacts on exports.
Similar trials are currently underway in the Netherlands, Italy, and the United States, indicating a growing global interest in vaccines as a tool for managing HPAI, though biosecurity remains the primary defense.
El Reino Unido comienza un ensayo de 24 semanas de la vacuna contra la gripe aviar en pavos para combatir la mortal HPAI, que cuesta hasta 174 millones de libras esterlinas anuales.